Subsequently, co-IP, p53 ubiquitination, and rescue experiments confirmed that WDR74 inhibits ferroptosis via the p53/SLC7A11 axis by promoting p53 degradation, thereby contributing to HCC progression and sorafenib resistance. Here, TP53 is linked to hepatocellular carcinoma.